HIV News and Research

RSS

Lifestyle intervention program can increase physical activity levels of adults at risk for type 2 diabetes

Adults at risk for type 2 diabetes or heart disease or both can substantially increase their physical activity levels through participating in a lifestyle intervention program developed at the University of Pittsburgh Graduate School of Public Health for use in community-settings, such as senior centers or worksites.

9 Jun 2016

Study finds differences in hospitalization trends for gout and rheumatoid arthritis

While hospitalizations related to rheumatoid arthritis have dropped considerably over the past two decades, hospitalizations primarily associated with gout have increased dramatically.

8 Jun 2016

Screening for syphilis in persons at risk for infection provides substantial benefit

The U.S. Preventive Services Task Force has found convincing evidence that screening for syphilis infection in asymptomatic, nonpregnant persons at increased risk for infection provides substantial benefit. The report appears in the June 7 issue of JAMA.

8 Jun 2016

Common angina drug can stimulate patient's own white blood cells to combat cryptococcosis

A drug, more commonly used in the treatment of angina, could be the focus of a new strategy in fighting the fatal fungal infection cryptococcosis

8 Jun 2016

New systems-based strategy may help accelerate TB drug discovery

The rise in multi-drug resistant (MDR) and extremely drug resistant (XDR) strains of Mycobacterium tuberculosis (MTB) is becoming a major cause of global health concern for treating tuberculosis, which affects a third of the global population.

7 Jun 2016

NHS England takes too long to commission PrEP for HIV prevention

An effective treatment that can prevent HIV infection and reduce the human and financial costs of the preventable condition is taking too long to be commissioned and made available on the NHS, warns Deborah Gold, chief executive of the National Aids Trust, in an article published by The BMJ today.

7 Jun 2016

Improved research tool may open door to effective HIV vaccine designs

Vaccines are usually medicine's best defense against the world's deadliest microbes. However, HIV is so mutable that it has so far effectively evaded both the human immune system and scientists' attempts to make an effective vaccine to protect against it.

6 Jun 2016

Overweight adolescents can increase physical activity by using their built environment

A program encouraging overweight or obese adolescents to increase their physical activity through use of their everyday environment, rather than organized classes or sports programs, produced significant increases in participants' daily physical activity that were sustained for at least three to four months.

3 Jun 2016

Fasnall drug appears to inhibit tumor growth by promoting cancer cell death

A promising new compound appears to impede a process that fuels breast cancer in mice, a discovery that could have implications in the treatment of a host of cancers.

3 Jun 2016

UBC study finds lower HIV testing rates among gay men living in small cities

Men who live outside major Canadian cities and have sex with other men are less likely to get an HIV test than their metropolitan counterparts, a UBC study shows.

2 Jun 2016

RNA molecular dynamics research provides key insights into new treatments for retroviral diseases

New molecular dynamics research into how RNA folds into hairpin-shaped structures called tetraloops could provide important insights into new treatments for retroviral diseases.

1 Jun 2016

Gonorrhoea infections increase across Europe

Since 2008, the overall rate of reported gonorrhoea infections has more than doubled across Europe, going up from 8 per 100 000 population to 20 cases per 100 000 persons in 2014.

1 Jun 2016

Sixty-ninth World Health Assembly comes to end after approving many new resolutions

The Sixty-ninth World Health Assembly closed today after approving new resolutions on WHO's Framework for Engagement with Non-State Actors; the Sustainable Development Goals; the International Health Regulations; tobacco control; road traffic deaths and injuries; nutrition; HIV, hepatitis and STIs; mycetoma; research and development; access to medicines and integrated health services.

31 May 2016

UN’s 90-90-90 program could be a cost-effective way to control global AIDS epidemic

A new study finds that implementing the United Nations targets for HIV testing and treatment would be an expensive but ultimately very cost-effective way to increase survival, reduce the number of children orphaned by HIV, and contain the global AIDS epidemic.

31 May 2016

ART alone not sufficient to reduce arterial inflammation among HIV-infected patients, study finds

Initiating antiretroviral therapy (ART) soon after diagnosis of an HIV infection did not prevent the progression of significant arterial inflammation in a small group of previously untreated patients.

26 May 2016

New approach offers unprecedented view of how HIV virus infects and appropriates host cell

Viruses attack cells and commandeer their machinery in a complex and carefully orchestrated invasion. Scientists have longed probed this process for insights into biology and disease, but essential details still remain out of reach.

25 May 2016

Telephone-based intervention helps reduce menopause-related insomnia, hot flashes

Chatting on the phone with a "sleep coach" and keeping a nightly sleep diary significantly improve sleep quality and reduce insomnia in women through all stages of menopause, according to a new study published today in JAMA Internal Medicine.

24 May 2016

Text messaging intervention may help smokers abstain from smoking relative to controls

A new study from The Miriam Hospital's Centers for Behavioral and Preventive Medicine found that smokers who received a text messaging intervention were more likely to abstain from smoking relative to controls. The paper is published in the Journal of Medical Internet Research mHealth and uHealth.

24 May 2016

Understanding structure of HIV-1 protease vital to development of next-generation HIV drugs

HIV, the virus that causes AIDS, has become one of the world’s most serious health and development challenges.

24 May 2016

Cochrane review explores FDCs versus single-drug formulations for treatment of pulmonary TB

A research team from Spain has prepared a Cochrane systematic review that explores the efficacy, safety, and adherence to fixed-dose combinations (FDCs) of drugs versus single-drug formulations to treat people who are newly diagnosed with tuberculosis (TB).

23 May 2016

HIV News and Research

Lifestyle intervention program can increase physical activity levels of adults at risk for type 2 diabetes

Study finds differences in hospitalization trends for gout and rheumatoid arthritis

Screening for syphilis in persons at risk for infection provides substantial benefit

Common angina drug can stimulate patient's own white blood cells to combat cryptococcosis

New systems-based strategy may help accelerate TB drug discovery

NHS England takes too long to commission PrEP for HIV prevention

Improved research tool may open door to effective HIV vaccine designs

Overweight adolescents can increase physical activity by using their built environment

Fasnall drug appears to inhibit tumor growth by promoting cancer cell death

UBC study finds lower HIV testing rates among gay men living in small cities

RNA molecular dynamics research provides key insights into new treatments for retroviral diseases

Gonorrhoea infections increase across Europe

Sixty-ninth World Health Assembly comes to end after approving many new resolutions

UN’s 90-90-90 program could be a cost-effective way to control global AIDS epidemic

ART alone not sufficient to reduce arterial inflammation among HIV-infected patients, study finds

New approach offers unprecedented view of how HIV virus infects and appropriates host cell

Telephone-based intervention helps reduce menopause-related insomnia, hot flashes

Text messaging intervention may help smokers abstain from smoking relative to controls

Understanding structure of HIV-1 protease vital to development of next-generation HIV drugs

Cochrane review explores FDCs versus single-drug formulations for treatment of pulmonary TB

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News